ISRCTN73232918已完成不适用
Primary prevention of rheumatoid arthritis
Jan van Breemen Instituut (Netherlands)0 个研究点目标入组 80 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 18 - 70 years for RF+, 18+ for aCCP
- •2. Twice increased Immunoglobulin M (IgM)-RF and/or aCCP with 4+ weeks interval
- •3. Human Leukocyte Antigen (HLA)-DR Shared Epitope (SE) positive
排除标准
- •Situations with possible false positive RF:
- •1. Auto-immune diseases
- •2. Active infection with hepatitis C or Ebstein Barr virus
- •3. Recent chemotherapy
- •4. Co-morbidity with decreased life expectancy
- •5. Corticosteroid use for another disease
- •6. Contra-indications for corticosteroids: diabetes mellitus, osteoporosis
- •7. Pregnancy or lactation
研究者
相似试验
进行中（未招募）
不适用
Prevention of clinically manifest rheumatoid arthritis by B cell directed therapy in the earliest phase of the disease.EUCTR2009-010955-29-NLDivision of Clinically Immunology and Rheumatology, AMC
尚未招募
不适用
Prevention of RA by B cell directed therapy.pre-clinical RANL-OMON28176Academic Medical Center/University of Amsterdam, Amsterdam90
招募中
不适用
Primary prevention of rheumatoid arthritis.rheumatoid arthritisNL-OMON26301Prof.dr. B.A.C. DijkmansVUMC/Jan van Breemen Instituut80
已完成
不适用
Active management of rheumatoid arthritis (RA)ISRCTN78142229Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)100
已完成
3 期
Prevention of rheumatoid arthritis by atorvastatin in seropositive arthralgia patients: a multi-center doubleblind randomized placebo-controlled trialarthritis10003816rheumatoid arthritisNL-OMON44914Reade